✦ LIBER ✦

Lamivudine therapy in HBsAg-carrying breast cancer patients undergoing chemotherapy: prophylactic or preemptive?

✍ Scribed by Ming-Shen Dai; Tsu-Yi Chao

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preemptive use of lamivudine in breast c

✍ Ming-Shen Dai; Pei-Fen Wu; Jang-Jih Lu; Rong-Yaun Shyu; Tsu-Yi Chao 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 184 KB

Hepatitis B virus reactivation in breast

✍ M. S. Dai; P. F. Wu; R. Y. Shyu; J. J. Lu; T. Y. Chao 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB

Preventing chemotherapy-induced hepatiti

✍ Shih-Hung Tsai; Ming-Shen Dai; Jyh-Cherng Yu; Ching-Liang Ho; Yeu-Chin Chen; Yi- 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 257 KB

Lamivudine for the prevention of hepatit

✍ W Yeo; W.M Ho; P Hui; C.K Lam; B Zee; W.H Kwan; P.K.S Chan; J.J Lee; P.J Johnson 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 179 KB

Prophylactic use of lamivudine for hepat

✍ Yun, J; Kim, K H; Kang, E S; Gwak, G-Y; Choi, M S; Lee, J E; Nam, S J; Yang, J-H 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 249 KB

The effect of prophylactic lamivudine on

✍ Xiao-Qin Chen, Jie-Wen Peng, Gui-Nan Lin, Mei Li, Zhong-Jun Xia 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 162 KB